|
Apr 4
|
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
|
|
Apr 2
|
5 Medical Product Stocks to Buy Amid Industry Challenges
|
|
Apr 1
|
ResMed Inc. (NYSE:RMD) is a favorite amongst institutional investors who own 61%
|
|
Apr 1
|
Here's Why Investors Should Buy ResMed (RMD) Stock Now
|
|
Jan 16
|
ResMed says its masks to remain on market despite FDA classification
|
|
Jan 14
|
ResMed Inc.'s (NYSE:RMD) Intrinsic Value Is Potentially 33% Above Its Share Price
|
|
Jan 12
|
Resmed’s magnetized masks linked to 6 patient injuries, FDA says
|
|
Jan 11
|
US FDA identifies recall of ResMed's respiratory devices as most serious
|
|
Dec 27
|
ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 22
|
Resmed posts notice about risk of mask magnets interfering with medical implants
|
|
Dec 20
|
ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices
|
|
Dec 8
|
ResMed's (NYSE:RMD) five-year earnings growth trails the 8.2% YoY shareholder returns
|
|
Dec 7
|
Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally
|
|
Dec 7
|
Why ResMed (RMD) is a Top Momentum Stock for the Long-Term
|
|
Dec 4
|
Resmed’s new C-suite focused on growing sleep apnea device demand: analysts
|
|
Dec 1
|
Envista (NVST) Up 6.8% Since Last Earnings Report: Can It Continue?
|
|
Dec 1
|
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
|
|
Nov 30
|
Insider Sell: CFO Brett Sandercock Sells 3,000 Shares of ResMed Inc (RMD)
|
|
Oct 19
|
ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
|
Oct 17
|
MedTech Earnings in the Age of Ozempic May Not Be That Bad
|